Skip to main content

Table 1 Baseline characteristics of included patients in the studies in Boende and Kabalo

From: Varying efficacy of artesunate+amodiaquine and artesunate+sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in the Democratic Republic of Congo: a report of two in-vivo studies

Characteristics N

Boende

Kabalo

SP

107

AQ

106

AS+SP

91

AS+AQ

90

SP

60

AS+SP

62

AS+AQ

58

Males, n (%)

56 (52.3)

54 (50.9)

45 (49.5)

46 (51.1)

26 (43.3)

37 (59.7)

36 (62.1)

Age months

median [range]

18

[6–59]

19

[6–59]

20

[6–56]

21

[6–56]

36

[8–96]

25

[7–108]

33.5

[7–108]

Weight kg

median [range]

9.2

[5.1–18]

10.3

[5.8–22]

9.7

[5.9–17]

9.9

[6.1–16.5]

11

[6–25]

11

[6.7–22]

11

[5.7–26]

MUAC mm

median [range]

140

[112–172]

142

[110–176]

142

[118–170]

138

[124–170]

146

[116–194]

148

[122–180]

149

[116–180]

Asexual parasitaemia (/μl), GMR* [range]

26724

[2080–187200]

28992

[2097–189037]

26662

[2171–163840]

26134

[2073–186400]

22501

[1995–181970]

20352

[2455–162181]

19934

[2455–147911]

Temperature °C

median [range]

38.5

[37.5–40.2]

38.6

[37.5–40.5]

38.5

[37.5–40.6]

38.7

[37.5–40.6]

38.4

[37.5–40.5]

38.4

[37.5–41.0]

38.4

[37.5–40.5]

  1. *GMR = geometric mean